From: Cerebral hemodynamics is altered in patients with sleep apnea/hypopnea syndrome
SAHS group | Control group | p | |
---|---|---|---|
n | 76 | 76 | |
Gender | 67 M/9 F | 66 M/10 F | 1 |
Age (years) | 48.3 ± 10,5 | 48.8 ± 11.2 | 0.8 |
BMI (kgs/m2) | 31.2 ± 4.6 | 26.9 ± 3.9 | <0.001 |
ESS | 12.7 ± 4.1 | 4.1 ± 1.8 | <0.001 |
HT | 21 (27.6 %) | 18 (23.6 %) | 0.5 |
Current smoking | 26 (34.2 %) | 27 (35.5 %) | 0.8 |
Dyslipidemia | 25 (32.8 %) | 21 (27.6 %) | 0.4 |
DM | 2 (2.6 %) | 2 (2.6 %) | 1 |
CD | 4 (5.3 %) | 2 (2.6 %) | 0.6 |
Peripheral arteriopathy | 0 | 0 | 1 |
Baseline MAP (mmHg) | 106 ± 14 | 98 ± 12 | 0.001 |
Post-apnea MAP (mmHg) | 109 ± 14 | 101 ± 11 | <0.001 |
∆MAP (mmHg) | +3.7 ± 10 | +2.7 ± 7 | 0.4 |
MFV (cms/sg) | 52 ± 9 | 60 ± 12 | <0.001 |
BHT (%) | 31 ± 12 | 36 ± 11 | 0.005 |